StaveMD vs ReadyRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

StaveMD

Provider comparison

Shoppers who want an oral or injectable compounded GLP-1 with easy cancellation and are willing to confirm the plan price at checkout.

Semaglutide / month: $199/moStarting price, compounded injection or dissolving tablet
Tirzepatide / month: $249/moStarting price, compounded

Index 77/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check StaveMD pricing Read review

ReadyRx

Provider comparison

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Semaglutide / month: $249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month: $315/moStanding one-month compounded plan; $295 first month with current public offer

Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

StaveMD has the higher Cost-Efficiency Index: 77/100 versus 76/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

StaveMD: All 50 states and D.C.
ReadyRx: All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

StaveMD

ReadyRx

Semaglutide / month: StaveMD: $199/moStarting price, compounded injection or dissolving tablet; ReadyRx: $249/moStanding one-month compounded plan; $229 first month with current public offer

Tirzepatide / month: StaveMD: $249/moStarting price, compounded; ReadyRx: $315/moStanding one-month compounded plan; $295 first month with current public offer

Semaglutide / year (modeled): StaveMD: $2,388; ReadyRx: $2,988

Tirzepatide / year (modeled): StaveMD: $2,988; ReadyRx: $3,780

State availability: StaveMD: All 50 states and D.C.; ReadyRx: All 50 states

Oral / sublingual option listed: StaveMD: Yes; ReadyRx: Not listed

Brand-name access listed: StaveMD: Not confirmed; ReadyRx: Yes

Provider facts checked: StaveMD: October 2026; ReadyRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

StaveMD

Shoppers who want an oral or injectable compounded GLP-1 with easy cancellation and are willing to confirm the plan price at checkout.

Reasons to consider it

Cancel any time from your account with no phone call or notice period, and request a refund for any month whose medication hasn't been ordered
Offers compounded semaglutide as a weekly injection or a daily dissolving tablet, plus tirzepatide and a lower-dose microdose program from $179 a month
Names its pharmacies, led by Red Rock Compounding Pharmacy in Utah, and its medical group, OpenLoop Healthcare Partners

What to weigh up

Every price is a "starting from" figure; the site says longer programs cost less per month and are billed upfront but doesn't print the price of each plan length
The banner's "Start for $179/mo" is the microdose program, not the standard semaglutide or tirzepatide dose
"Trusted by millions" and "3,000,000+ members" are totals for its telehealth partner's whole network, as a footnote admits, not StaveMD patients

Compounded drugs are not FDA-approved. Understand the medication options.

Check StaveMD pricing Read the full StaveMD review

ReadyRx

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Reasons to consider it

Current one-month renewal rates are $249 semaglutide and $315 tirzepatide
The public price calculator separates first-month discounts from renewal prices
Provider messaging, shipping, protocols, meal plans and coaching are included

What to weigh up

Headline first-month offers are lower than the recurring price
The lower $179 semaglutide first-month offer is calculated for the quarterly plan
Cancel at least four business days before renewal; shipments can be processed early

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read the full ReadyRx review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

StaveMDReadyRx

Normalized Cost/Month: StaveMD:
60/100; ReadyRx:
61/100

Price Transparency: StaveMD:
84/100; ReadyRx:
94/100

Nationwide Access: StaveMD:
86/100; ReadyRx:
86/100

Formulation Options: StaveMD:
77/100; ReadyRx:
79/100

Clinical Oversight: StaveMD:
73/100; ReadyRx:
79/100

Contract Flexibility: StaveMD:
91/100; ReadyRx:
55/100

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to StaveMD Alternatives to ReadyRx

More provider matchups

CoreAge Rx vs StaveMD CoreAge Rx vs ReadyRx

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.